
Himadri Speciality Chemical Approves FY26 Results, Recommends Dividend, and Plans China Subsidiary Expansion
Himadri Speciality Chemical Limited, formerly Himadri Chemicals & Industries Limited, announced on April 23, 2026, the outcomes of its Board of Directors meeting. The Board approved the audited financial results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026, and recommended a final dividend for the financial year 2025-26.Financial Results and Dividend Recommendation
The Board recommended a final dividend of Re. 0.80 per equity share of Re. 1 each for the financial year 2025-26, subject to shareholder approval.The company released comprehensive financial data, detailing performance for the year ended March 31, 2026, compared to the previous year ending March 31, 2025.
Key financial metrics (in Rs. in Crores):
| Metric | Year Ended 31.03.2026 | Previous Year Ended 31.03.2025 |
|---|---|---|
| Total Revenue from Operations (Consolidated) | 4,660.70 | 4,612.63 |
| Total Income (Consolidated) | 4,831.99 | 4,664.32 |
| Net Profit after tax (Consolidated) | 755.07 | 555.09 |
| Total Comprehensive Income (Consolidated) | 763.81 | 574.62 |
Segment-wise revenue details confirm the performance across key business units:
| Segment | Three Months Ended 31.03.2026 | Previous Three Months Ended 31.12.2025 | Corresponding Three Months Ended 31.03.2025 |
|---|---|---|---|
| Carbon materials and chemicals Revenue | 1,123.90 | 1,110.47 | 1,128.57 |
| Power Revenue | 25.54 | 21.52 | 24.98 |
| Total Revenue from Operations | 1,287.76 | 1,183.62 | 1,134.64 |
Corporate Governance and Strategy
The Board approved several governance appointments and strategic initiatives:Board Appointments:
1. Independent Directors: The Board recommended the re-appointment of Mr. Girish Paman Vanvari and Mr. Gopal Ajay Malpani as Independent Directors for a second term of five consecutive years. The appointments are subject to shareholder approval.
2. Internal Auditor: M/s Ernst & Young, LLP, was re-appointed as the Internal Auditor for the financial year 2026-27.
3. Cost Auditor: Mr. Sambhu Banerjee was appointed as the Cost Auditor for the financial year 2026-27.
Strategic Expansion:
The Board approved the proposal to incorporate a foreign wholly owned step-down subsidiary in Guangzhou, China. The subsidiary will be involved in trading chemical and allied products, plant and machineries, equipment, and other capital goods, with the primary objective of expanding the company's business globally.
Operational Milestones
During the meeting, the company highlighted significant operational milestones in its manufacturing capabilities:- Carbon Black Line: The company successfully completed the brownfield expansion for a new Speciality Carbon Black line of 70,000 MTPA at its manufacturing facility in Mahistikry, Hooghly, West Bengal. Commercial Operations for this expanded capacity began on February 24, 2026.
- Anode Material Facility: On April 23, 2026, the company achieved a milestone with the commencement of its first anode material production facility at Mahistikry, Hooghly, West Bengal, with an initial capacity of 200 MTPA.
Key Financial Statements Summary
For detailed review, the audited standalone and consolidated financial statements are available. The consolidated statement of assets and liabilities and the consolidated statement of cash flows reflect a total equity of 4,762.08 Rs. in Crores as of March 31, 2026, compared to 3,770.94 Rs. in Crores in the previous year.HSCL Stock Price Movement
Today, Himadri Speciality Chemical Limited (HSCL) shares edged higher to close at ₹536.2, settling for a gain of 2.85%. The stock experienced significant momentum today, rallying on 3.98 million shares and successfully hitting a 52-week high of ₹538.2 during trading.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.